Nabil Uddin
Corporate Officer/Principal bei CONCERT PHARMACEUTICALS, INC.
Profil
Nabil Uddin is currently working as the Vice President-Corporate Development at Concert Pharmaceuticals, Inc. He holds a doctorate degree from the Massachusetts College of Pharmacy & Health Science and an undergraduate degree from McMaster University.
Aktive Positionen von Nabil Uddin
Unternehmen | Position | Beginn |
---|---|---|
CONCERT PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Nabil Uddin
McMaster University | Undergraduate Degree |
Massachusetts College of Pharmacy & Health Science | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Concert Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |